entertainment -WSS

entertainment

author：entertainment 2025-09-02 22:06:30 - browse：7

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Commercial surrogacy can be ethical, despite pope’s claims

knowledge

hotspot

WSS

FDA drug safety: Singulair case shows systemic surveillance flaws

Just how do doctors, lawmakers, and the public define abortion?

With psoriasis trial ahead, Alumis raises $259 million

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

FDA drug safety: Singulair case shows systemic surveillance flaws

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

knowledge

entertainment

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cognito secures funding to test medical device for Alzheimer's

Continuity nursing helped my family in our darkest PICU moments

Change Healthcare cyberattack prompts Medicare loan program

Malaria cases in Florida and Texas: Here’s what you need to know

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Do digital therapeutics have a future in medicine?

Dobbs anniversary: the lost opportunity of abortion as health care

First medicine developed to treat MASH expected to be approved soon

knowledge

Change Healthcare payments predicted restored March 15

Apple Vision Pro: A first look at health apps on the new VR headset

Air quality improving but still lags in Black, Hispanic communities

A $475,000 price tag for a new cancer drug: crazy or meh?

Sen. Paul opposes bill to ban Chinese biotechs

The lessons of Aduhelm, an Alzheimer's drug that was not to be

knowledge

entertainment

hotspot

Wikipedia